XTXXF
Adastra Holdings Ltd.
$0.01
+0.00 (+0.00%)
At close · Jul 2
Market Cap
$111,941
Shares
5,597,050
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.02
Day$0.02–0.02
52W$0.01–0.51
Avg vol 30d3
Short int140 · 0.0% float · 2.8d
DataJul 2021–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−88% below
◦
Price vs 50-day avg
−3% below
◦
RSI (14)
0 · oversold
+
MACD trend
positive
−
52-week position
0% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $0 › 200d $0 — 200d above 50d
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.00% of float · 2.8 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−88% below
Bearish
Price vs 50-day avg
−3% below
Neutral
RSI (14)
0 · oversold
Neutral
MACD trend
positive
Bullish
52-week position
0% · near low
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $1
vs 200-day avg -88%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XTXXF
this stock
Adastra Holdings Ltd.
|
$111,941 | -30.0% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.37B | +8.3% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.80B | -3.9% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XTXXF | +0.0% | +0.0% | -30.0% | +0.0% | -30.0% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.4% | +1.3% | -38.0% | +0.3% | -39.2% |